Your browser doesn't support javascript.
loading
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status.
Irelli, Azzurra; Parisi, Alessandro; D'Orazio, Carla; Sidoni, Tina; Rotondaro, Silvia; Patruno, Leonardo; Pavese, Francesco; Bafile, Alberto; Resta, Valter; Pizzorno, Laura; Ciuffetelli, Virginia; Dal Mas, Antonella; Calvisi, Giuseppe; Di Sibio, Alessandra; Marzullo, Anna; Zelli, Veronica; Compagnoni, Chiara; Tessitore, Alessandra; Alesse, Edoardo; Ficorella, Corrado; Cortellini, Alessio; Cannita, Katia.
Afiliação
  • Irelli A; Medical Oncology Unit, Department of Oncology, AUSL 04 Teramo, 64100 Teramo, Italy.
  • Parisi A; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
  • D'Orazio C; Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, 60126 Ancona, Italy.
  • Sidoni T; Medical Oncology, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Rotondaro S; Medical Oncology, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Patruno L; Medical Oncology, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Pavese F; Medical Oncology, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Bafile A; Medical Oncology, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Resta V; Breast Unit, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Pizzorno L; Breast Unit, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Ciuffetelli V; Breast Unit, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Dal Mas A; Pathology Unit, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Calvisi G; Pathology Unit, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Di Sibio A; Pathology Unit, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Marzullo A; Radiology Unit, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Zelli V; Nuclear Medicine Unit, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Compagnoni C; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
  • Tessitore A; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
  • Alesse E; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
  • Ficorella C; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
  • Cortellini A; Medical Oncology, St. Salvatore Hospital, 67100 L'Aquila, Italy.
  • Cannita K; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK.
Cancers (Basel) ; 14(12)2022 Jun 18.
Article em En | MEDLINE | ID: mdl-35740668
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália